Records containing: Meningococcal Infections
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-12-01Multicenter, Randomized, Subject/Evaluator Blind, Active Control, Phase II/III Clinical Trial to Assess Immunogenicity and Safety of EG-MCV4 Meningococcal (Groups A, C, W-135, and Y) Conjugated Vaccines
-
CLINICAL_TRIALS study record update · 2025-11-10Effectiveness of Azithromycin in Eradicating Nasopharyngeal Carriage of N. Meningitidis
-
CLINICAL_TRIALS study record update · 2025-01-22Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe
-
CLINICAL_TRIALS study record update · 2023-08-28Septic cArdiac Deficiency and MenIngococcal seveRe Sepsis
-
CLINICAL_TRIALS study record update · 2023-08-09Epidemiological, Clinical and Biological Caracteristics of Patients Presenting With Invasive Meningococcal Disease in the West of France
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-03-09The Long-term Impact of Invasive Meningococcal Disease in Australian Adolescents and Young Adults
-
CLINICAL_TRIALS study record update · 2022-04-25Observational Study of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine Menactra® Administered in Individuals 2 Through 55 Years Old Under Standard Health Care Practice in the Russian Federation
-
CLINICAL_TRIALS study record update · 2022-04-25Postmarketing Surveillance Study for Use of Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra®) in the Republic of Korea
-
CLINICAL_TRIALS study record update · 2022-03-17A Surveillance Study on Timing and Coverage Of Rotavirus and MenB Vaccine Co-administration in Campania Region, Italy
-
CLINICAL_TRIALS study record update · 2021-10-27Investigating Meningococcal Vaccines in Adults - An Exploratory, Open-label, Immunogenicity Study of a Licensed Meningococcal Capsular Group B Vaccine (4CMenB, Bexsero®) in Adults
-
CLINICAL_TRIALS study record update · 2021-05-06Safety and Immunogenicity Following Meningococcal and Pneumococcal Immunization Among Adult People Living With HIV: A Single Center, Non-blinded, Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2021-02-02Immunogenicity of a U.S.-Licensed Meningococcal Serogroup B Vaccine (Trumenba) in Adults at Increased Risk of Meningococcal Disease Because of Occupational Exposure
-
CLINICAL_TRIALS study record update · 2020-10-01Response of United Kingdom (UK) Infants to a Reduced Primary Schedule With Meningococcal C and Pneumococcal Conjugate Vaccines
-
CLINICAL_TRIALS study record update · 2020-06-09Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Toddlers 12 to 23 Months of Age.
-
CLINICAL_TRIALS study record update · 2020-06-09A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents
-
CLINICAL_TRIALS study record update · 2020-06-09Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered in Subjects 56 Years of Age and Older
-
CLINICAL_TRIALS study record update · 2020-06-09Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
-
CLINICAL_TRIALS study record update · 2020-06-05Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered as a Booster Dose in Children Vaccinated 3 Years Earlier as Toddlers
-
CLINICAL_TRIALS study record update · 2020-06-05Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adolescents and Adults
-
CLINICAL_TRIALS study record update · 2020-06-05A Phase II Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Toddlers
-
CLINICAL_TRIALS study record update · 2020-03-09Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adolescents and Adults Aged 10 to 55 Years
-
CLINICAL_TRIALS study record update · 2020-02-18Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults Age 56 Years and Older
-
CLINICAL_TRIALS study record update · 2020-01-22Phase I Clinical Study of Meningococcal Group ACYW135 Conjugate Vaccine
-
CLINICAL_TRIALS study record update · 2019-12-12Petechiae In Children (PIC) Study
-
CLINICAL_TRIALS study record update · 2019-08-07Interaction Between Meningococcal Serogroup B Vaccine (Bexsero™) and Routine Infant Vaccines on the Risk of Occurrence and Recurrence of Adverse Events Following Immunization.